跳至主要内容
临床试验/KCT0009401
KCT0009401已完成未知

A 12-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of HUN2-483 on Cognitive Function Improvement

Huons0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40(Year) 至 85(Year)(—)
性别
All

入选标准

  • 1) Adult aged 40 to under 85
  • 2) Koreans who can decipher Korean language
  • 3) Participants who have mini mental state examination score of 18 to 28
  • 4) A person who agrees to participate in this study before the start of the study and prepares a written consent form

排除标准

  • 1) A person currently being treated for severe cardiovascular, respiratory, immune, gastrointestinal/hepatic and biliary systems, kidney and urology, nervous, musculoskeletal, infectious diseases and malignant tumors
  • 2) A Persons who has neuropsychological disease such as depression (based on DSM-5), schizophrenia, alcoholism, and drug dependence
  • 3) A person who has a disease accompanied by cognitive impairment, such as dementia (based on DSM-5) and Parkinson's disease
  • 4) A person diagnosed with an intellectual disability

研究者

发起方
Huons

相似试验